Tools for Identifying Cancer Pain of Predominantly Neuropathic Origin and Opioid Responsiveness in Cancer Patients

Journal of Pain

Volumn 10, Issue 6, 2009, Pages 594-600

  Mercadante, Sebastiano ^a,b   Gebbia, Vittorio ^a   David, Fabrizio ^a   Aielli, Federica ^a   Verna, Lucilla ^a   Casuccio, Alessandra ^c   Porzio, Giampiero ^a   Mangione, Salvatore ^b   Ferrera, Patrizia ^a  

^a LA MADDALENA CANCER CENTER   (Italy)

^b Anesthesia and Intensive Care Unit   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

Author keywords

assessment tools; Cancer pain; neuropathic pain; opioid response

Indexed keywords

OPIATE DERIVATIVE;

AGED; ARTICLE; CANCER PAIN; CANCER PATIENT; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; LEEDS ASSESSMENT OF NEUROPATHIC SIGNS AND SYMPTOMS; MAJOR CLINICAL STUDY; MALE; NEUROPATHIC PAIN; NEUROPATHIC PAIN QUESTIONNAIRE; NEUROPATHIC PAIN SYMPTOM INVENTORY; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PATIENT CODING; PATIENT SELECTION; SENSITIVITY AND SPECIFICITY; SINGLE BLIND PROCEDURE; UNSPECIFIED SIDE EFFECT;

AGED; ANALGESICS, OPIOID; FEMALE; HUMANS; MALE; NEOPLASMS; PAIN; PAIN MEASUREMENT; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 67349095016     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2008.12.002     Document Type: Article

References (34)

1. Attal N., and Bouhassira D. Can pain be more or less neuropathic?. Pain 110 (2004) 510-511
2. Backonja M.M., and Krause S. Neuropathic pain questionnaire - short form. Clin J Pain 19 (2003) 305-316
3. Bennett M. The LANSS pain scale: The Leeds assessment of neuropathic symptoms and signs. Pain 92 (2001) 147-157
4. Bennett M.I., Smith B.H., Torrance N., and Potter J. The S-LANSS score for identifying pain of predominantly neuropathic origin: Validation for use in clinical and postal research. J Pain 6 (2005) 149-158
5. Bennett M.I., Smith B.H., Torrance N., and Lee A.J. Can pain can be more or less neuropathic? Comparison of symptom assessment tools with ratings of certainty by clinicians. Pain 122 (2006) 289-294
6. Bennett M.I., Attal N., Backonja M.M., Baron R., Bouhassira D., Freynhagen R., Scholz J., Tolle T.R., Wittchen H., and Jensen T.S. Using screening tools to identify neuropathic pain. Pain 127 (2007) 199-203
7. Bennett M.I., and Bouhassira D. Epidemiology of neuropathic pain: Can we use the screening tools?. Pain 132 (2007) 12-13
8. Bouhassira D., Attal N., Fermanian J., Alchaar H., Gautron M., Masquelier E., Rostaing S., Lanteri-Minet M., Collin E., Grisart J., and Boureau F. Development and validation of the Neuropathic Pain Symptom Inventory. Pain 108 (2004) 248-257
9. Bouhassira D., Attal N., Alchaar H., Boureau F., Brochet B., Bruxelle J., Cunin G., Fermanian J., Ginies P., Grun-Overdyking A., Jafari-Schluep H., Lantéri-Minet M., Laurent B., Mick G., Serrie A., Valade D., and Vicaut E. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 114 (2005) 29-36
10. Bruera E., MacMillan D., Hanson J., and MacDonald R.N. The Edmonton staging system for cancer pain: Preliminary report. Pain 37 (1989) 203-210
11. Caraceni A., Mendoza T.R., Mencaglia E., Baratella C., Edwards K., Forjaz M.J., Martini C., Serlin R.C., de Conno F., and Cleeland C.S. A validation study of an Italian version of the Brief Pain Inventory (Breve Questionario per la Valutazione del Dolore). Pain 65 (1996) 87-92
12. Caraceni A., and Portenoy R.K. An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. Pain 82 (1999) 263-274
13. Davis M.P. What is new in neuropathic pain?. Support Care Cancer 15 (2007) 363-372
14. De Benedittis G., Massei R., Nobili R., and Pieri A. The Italian Pain Questionnaire. Pain 33 (1988) 53-62
15. Devor M. Neuropathic pain: What do we do with all these theories?. Acta Anaesthesiol Scand 45 (2001) 1121-1127
16. Finnerup N.B., Otto M., McQuay H.J., Jensen T.S., and Sindrup S.H. Algorithm for neuropathic pain treatment: An evidence-based proposal. Pain 118 (2005) 289-305
17. Finnerup N.B., and Jensen T.S. Mechanisms of disease: Mechanism-based classification of neuropathic pain-a critical analysis. Nat Clin Pract Neurol 2 (2006) 107-115
18. Galer B., and Jensen M.P. Development and preliminary validation of a pain measure specific to neuropathic pain: The neuropathic pain scale. Neurology 48 (1997) 332-338
19. Grond S., Radbruch L., Meuser T., Sabatowsky R., Loick G., and Lehmann K.A. Assessment and treatment of neuropathic cancer pain following WHO guidelines. Pain 79 (1999) 5-20
20. Krause S.J., and Backonja M.M. Development of a neuropathic pain questionnaire. Clin J Pain 19 (2003) 306-334
21. Jensen T.S., Gottrup H., Sindrup S., and Bach F.W. The clinical picture of neuropathic pain. Eur J Pharmacol 429 (2001) 1-11
22. Jensen T.S., and Baron R. Translation of symptoms and signs into mechanisms in neuropathic pain. Pain 102 (2003) 1-8
23. Mao J. Translational pain research: Bridging the gap between basic and clinical research. Pain 97 (2002) 183-187
24. Mercadante S., Fulfaro F., Casuccio A., and Barresi L. Investigation of an opioid response categorization in advanced cancer patients. J Pain Symptom Manage 18 (1999) 347-352
25. Mercadante S., and Portenoy R.K. Opioid poorly-responsive cancer pain. Part 1: Clinical considerations. J Pain Symptom Manage 21 (2001) 144-150
26. Mercadante S., Ferrera P., Villari P., and Casuccio A. Rapid switching between transdermal fentanyl and methadone in cancer patients. J Clin Oncol 23 (2005) 5229-5334
27. Mercadante S., and Bruera E. Opioid switching. A systematic and critical review 32 (2006) 304-315
28. Portenoy R.K., Foley K.M., and Inturrisi C.E. The nature of opioid responsiveness and its implications for neuropathic pain: New hypothesies derived from studies of opioid infusions. Pain 43 (1990) 273-286
29. Potter J., Higginson I.J., Scadding J.W., and Quigley C. Identifying neuropathic pain in patients with head and neck cancer: Use of the Leeds Assessment of Neuropathic Symptoms and Signs Scale. J R Soc Med 96 (2003) 379-383
30. Rasmussen P.V., Sindrup S.H., Jensen T.S., and Bach F.W. Symptoms and signs in patients with suspected neuropathic pain. Pain 110 (2004) 461-469
31. Rasmussen P.V., Sindrup S.H., Jensen T.S., and Bach F.W. Therapeutic outcome in neuropathic pain: Relationship to evidence of nervous system lesion. Eur J Neurology 11 (2004) 545-553
32. Sindrup S.H., and Jensen T.S. Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action. Pain 83 (1999) 389-400
33. Stute P., Soukup J., Menzel M., Sabatowski R., and Grond S. Analysis and treatment of different types of neuropathic cancer pain. J Pain Symptom Manage 26 (2003) 1123-1131
34. Treede R.D., Jensen T.S., Campbell J.N., Cruccu G., Dostrowsky J.O., Griffin J.W., Hansson P., Hughes R., Nurmikko T., and Serra J. Neuropathic pain. Redefinition and a grading system for clinical and research purposes. Neurology 70 (2008) 1630-1635